Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Sell
485
-389
-45% -$180K 0.02% 520
2026
Q1
$420K Sell
874
-137
-14% -$70.1K 0.04% 341
2025
Q4
$568K Buy
+1,011
New +$574K 0.05% 267

Other funds holding MEDP

Sentinus LLC's MEDP Position: Q2 2026 in Review

Sentinus LLC reduced its Medpace (MEDP) stake by 45% in Q2 2026, selling an estimated $180K and leaving 485 shares worth $257K. The position accounts for 0.02% of the portfolio, ranked #520.

Sentinus LLC first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $568K in Q4 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Sentinus LLC held 485 shares of Medpace worth $257K as of Q2 2026.
  • Sentinus LLC sold 389 Medpace shares in Q2 2026, an estimated $180K.
  • Medpace made up 0.02% of Sentinus LLC's portfolio in Q2 2026, its #520 holding.
  • Sentinus LLC first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Sentinus LLC's Medpace position peaked at $568K in Q4 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.